Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deutsch

Showing results (31-40 of 350) with videos related to

Pageof 35
Sort By:
Frontiers in Immunology|June 26, 2025
Editorial: Artificial intelligence for cancer immunotherapyIssam El Naqa, Shari Pilon-Thomas, Eric Deutsch
Frontiers in Immunology|May 13, 2025
Deep learning for malignant lymph node segmentation and detection: a reviewWenxia Wu, Adrien Laville, Eric Deutsch, et al.
Nature Clinical Practice. Oncology|November 3, 2005
New concepts for phase I trials: evaluating new drugs combined with radiation therapyEric Deutsch, Jean Charles Soria, Jean Pierre Armand
Nature Clinical Practice. Oncology|September 28, 2007
Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancerYungan Tao, Valentina Pinzi, Jean Bourhis, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|March 4, 2017
Candidate immune biomarkers for radioimmunotherapyAntonin Levy, Giulia Nigro, Philippe J Sansonetti, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2016
Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trialAntonin Levy, Christophe Massard, Jean-Charles Soria, et al.
Cancer Metastasis Reviews|June 19, 2012
Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?Céline Bourgier, Antonin Levy, Marie-Catherine Vozenin, et al.
Current Opinion in Oncology|March 30, 2021
Perspectives in pathomics in head and neck cancerMarion Classe, Marvin Lerousseau, Jean-Yves Scoazec, et al.
Advances in Radiation Oncology|August 11, 2020
Brachytherapy Issues and Priorities in the Context of the Coronavirus Disease 2019 (COVID-19) OutbreakCyrus Chargari, Supriya Chopra, Akila N Viswanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Drug-Radiotherapy Combination Trial Developments-ResponseEric Deutsch, Cyrus Chargari, Ralph R Weichselbaum, et al.
Pageof 35

Showing results (31-40 of 350) with videos related to

Sort By:
Pageof 35
Frontiers in Immunology|June 26, 2025
Editorial: Artificial intelligence for cancer immunotherapyIssam El Naqa, Shari Pilon-Thomas, Eric Deutsch
Frontiers in Immunology|May 13, 2025
Deep learning for malignant lymph node segmentation and detection: a reviewWenxia Wu, Adrien Laville, Eric Deutsch, et al.
Nature Clinical Practice. Oncology|November 3, 2005
New concepts for phase I trials: evaluating new drugs combined with radiation therapyEric Deutsch, Jean Charles Soria, Jean Pierre Armand
Nature Clinical Practice. Oncology|September 28, 2007
Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancerYungan Tao, Valentina Pinzi, Jean Bourhis, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|March 4, 2017
Candidate immune biomarkers for radioimmunotherapyAntonin Levy, Giulia Nigro, Philippe J Sansonetti, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2016
Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trialAntonin Levy, Christophe Massard, Jean-Charles Soria, et al.
Cancer Metastasis Reviews|June 19, 2012
Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?Céline Bourgier, Antonin Levy, Marie-Catherine Vozenin, et al.
Current Opinion in Oncology|March 30, 2021
Perspectives in pathomics in head and neck cancerMarion Classe, Marvin Lerousseau, Jean-Yves Scoazec, et al.
Advances in Radiation Oncology|August 11, 2020
Brachytherapy Issues and Priorities in the Context of the Coronavirus Disease 2019 (COVID-19) OutbreakCyrus Chargari, Supriya Chopra, Akila N Viswanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Drug-Radiotherapy Combination Trial Developments-ResponseEric Deutsch, Cyrus Chargari, Ralph R Weichselbaum, et al.
Pageof 35